Randomized controlled clinical trial of a combination therapy of vildagliptin plus an α-glucosidase inhibitor for patients with type II diabetes mellitus

The aim of this study was to assess the efficacy of a combination therapy of vildagliptin plus an α-glucosidase inhibitor for patients with type II diabetes mellitus. Type II diabetic patients exhibiting poor glycemic control following α-glucosidase inhibitor treatment for at least two months were s...

Descripción completa

Detalles Bibliográficos
Autores principales: SU, YONG, SU, YA-LI, LV, LI-FANG, WANG, LI-MIN, LI, QUAN-ZHONG, ZHAO, ZHI-GANG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043567/
https://www.ncbi.nlm.nih.gov/pubmed/24926379
http://dx.doi.org/10.3892/etm.2014.1637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043567/
https://www.ncbi.nlm.nih.gov/pubmed/24926379
http://dx.doi.org/10.3892/etm.2014.1637

Ejemplares similares